Quintrio
Home

CHEMICALS & ALLIED PRODUCTS

Innospec Inc.

IOSP

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.

Last trade $77.99
Day change -$1.185 (-1.50%)
Day range $77.46 – $79.24
Volume 67,265
Market cap $1.95B

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$1.95B
Price / earnings
13.89×
Price / book
1.42×
Price / sales
1.04×
EV / sales
0.91×
EV / EBITDA
8.59×

Profitability

Earnings per share
$5.70
Return on assets
7.56%
Return on equity
10.23%
Dividend yield
2.27%

Liquidity and leverage

Debt / equity
0×
Current ratio
2.95×
Quick ratio
1.92×
Cash ratio
0.72×

Cash flow

Price / cash flow
18.82×
Price / free cash flow
41.85×
Free cash flow
$46.6M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for IOSP, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$473.6M$491.4M$453.2M$455.6M$441.9M$439.7M$440.8M$466.8M
Cost of revenue$344.5M$353.1M$329.7M$328.2M$325.2M$316.5M$315.7M$330.6M
Gross profit$129.1M$138.3M$123.5M$127.4M$116.7M$123.2M$125.1M$136.2M
Selling, general and administrative$71.7M$84.3M$78.5M$69.3M$71.9M$74.6M$69.3M$78.9M
Research and development$16.8M$14.2M$13.2M$11M$13.7M$13.6M$12.7M$14.9M
Total operating expenses$88.5M$98.6M$91.7M$80.6M$128.5M$89M$82M$250.7M
Operating income$40.6M$39.7M$31.8M$46.8M-$11.8M$34.2M$43.1M-$114.5M
Interest expense$0$0$0$0$0$0$0$0
Income before taxes$42.6M$41.6M$39.9M$50.3M$11.3M$32.3M$45.2M-$102.6M
Income taxes$11M$10.4M$9.1M$2.9M-$1.4M$8.4M$11.6M-$32.2M
Net income$31.6M$31.2M$30.8M$47.4M$12.7M$23.9M$33.6M-$70.4M
Net income attributable to common shareholders$31.8M$30.8M$30.4M$47.4M$12.9M$23.5M$32.8M-$70.4M
EBITDA$50.2M$49.7M$41.7M$56.2M$43.3M$45.3M$54M-$103.6M
Basic earnings per share$1.29$1.25$1.23$1.91$0.52$0.94$1.31-$2.82
Diluted earnings per share$1.29$1.25$1.22$1.90$0.52$0.94$1.31-$2.79

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Innospec's Q3 Earnings Beat Estimates on Chemicals Strength

Innospec Inc. reported Q3 2026 adjusted EPS of $1.29, up 15.2% year-over-year and beating consensus estimates by 2.4%. Performance Chemicals saw operating income surge 83.7% driven by favorable pricing and product mix, while Oilfield Services grew 39.6% in operating income. However, revenues of $473.6 million missed estimates, and Fuel Specialties showed modest growth. The company ended the quarter debt-free with $251.9 million in cash.

Zacks Investment Research

Innospec (IOSP) Q3 Earnings Beat Estimates

Innospec reported Q3 2026 earnings of $1.29 per share, beating consensus estimates of $1.26, but revenues of $473.6 million missed expectations by 1.16%. The stock has gained 30.1% year-to-date, outperforming the S&P 500's 10.2% gain. However, the company received a Zacks Rank #3 (Hold) rating due to mixed estimate revisions, and its industry (Chemical - Diversified) ranks in the bottom 16% of Zacks industries.

Zacks Investment Research

Albemarle (ALB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Albemarle is expected to report Q3 2026 earnings of $2.41 per share (up 1368.4% YoY) with revenues of $1.49 billion (up 14.2% YoY) on November 4. However, the consensus EPS estimate has been revised 21.37% lower over the last 30 days, and the company has a negative Earnings ESP of -5.79% combined with a Zacks Rank #3, making it difficult to predict an earnings beat. The company beat estimates in 3 of the last 4 quarters.

Zacks Investment Research

Are Basic Materials Stocks Lagging Avient (AVNT) This Year?

Avient (AVNT) and Innospec (IOSP), both Basic Materials stocks with Zacks Rank #2 (Buy), are outperforming their sector peers year-to-date. AVNT has returned 24.8% versus the sector average of 9.5%, while IOSP has gained 26.2%. Both stocks have seen improving analyst sentiment with consensus EPS estimates increasing 4% over the past three months.

Zacks Investment Research

Here's Why You Should Hold DOW Stock in Your Portfolio for Now

Dow Inc. (DOW) is benefiting from high-return growth projects, cost initiatives, and advantaged feedstock positions, with over $1.3 billion in self-help benefits expected in 2026. However, the company faces headwinds from soft demand, seasonal construction weakness, and elevated energy and feedstock costs. DOW carries a Zacks Rank #3 (Hold) rating.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily
Declared upcoming dividend $0.94 per share
Declared
May 1, 2026
Ex-dividend
Nov 17, 2026
Pay date
Nov 25, 2026
Ex-dividendAmount / sharePay dateType
May 19, 2026$0.92May 29, 2026recurring
Nov 18, 2025$0.87Nov 26, 2025recurring
May 20, 2025$0.84May 30, 2025recurring
Nov 18, 2024$0.79Nov 26, 2024recurring
May 17, 2024$0.76May 31, 2024recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Jul 23, 20072-for-1forward split